TGS Financial Statements & Analysis
Complete financial statements for TGS including income statement, balance sheet, and cash flow statement. Analyze TGS's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
64.8% ↑
Net Income
32.5% ↑
Gross Margin
2.4% ↑
Operating Margin
-6.7% ↓
Balance Sheet
Current Ratio
83.1% ↑
Debt to Equity
126.2% ↓
Asset Turnover
3.3% ↑
Cash Flow
Operating Cash Flow
32.7% ↑
Net Cash Flow
1477.5% ↑
Free Cash Flow
38.6% ↑
Cash Flow to Debt
-58.1% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 1.21T | 1.99T | 64.8% | |
| Gross Profit | 631.37B | 1.06T | 68.7% | |
| Operating Income | 560.30B | 860.99B | 53.7% | |
| Net Income | 370.16B | 490.32B | 32.5% | |
| EPS | 2458.70 | 3250.25 | 32.2% | |
| EBITDA | 767.48B | 1.09T | 41.9% | |
| Gross Margin | 52.33% | 53.57% | 2.4% | |
| Operating Margin | 46.44% | 43.31% | 6.7% | |
| Net Income Margin | 30.68% | 24.67% | 19.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.99T | 1.21T | 967.50B | — | — |
| Gross Profit | 1.06T | 631.37B | 347.43B | — | — |
| Operating Income | 860.99B | 560.30B | 253.56B | — | — |
| Net Income | 490.32B | 370.16B | 51.21B | — | — |
| EPS | 3250.25 | 2458.70 | 156.20 | — | — |
| EBITDA | 1.09T | 767.48B | 280.66B | — | — |
| Gross Margin | 53.57% | 52.33% | 35.91% | — | — |
| Operating Margin | 43.31% | 46.44% | 26.21% | — | — |
| Net Income Margin | 24.67% | 30.68% | 5.29% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into TGS's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics